1-20 of 126
Ute Hegenbart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

Clinical Trials & Observations
Rajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, Divaya Bhutani, Morie A. Gertz, Angela Dispenzieri, Shaji Kumar, Anita D’Souza, Anannya Patwari, Andrew Cowan, GuiZhen Chen, Paolo Milani, Giovanni Palladini, Vaishali Sanchorawala, Geethika Bodanapu, Stefan O. Schönland, Suzanne Lentzsch, Eli Muchtar
Journal: Blood
Blood (2024) 144 (25): 2613–2624.
https://doi.org/10.1182/blood.2024025899
Published: 2024
Includes: Supplemental data
Journal Articles

Expanding the Eureka Study: Integrating a Comprehensive Clinical Registry with Molecular Profiling to Advance AL Amyloidosis Research

Mario Nuvolone, Ute Hegenbart, Bruno Paiva, Monique C. Minnema, Enkelejda Miho, Marta Lasa, Paolo Milani, Alain van Mil, Marish I. F. Oerlemans, Jan Kruta, Ramon Lecumberri Villamediana, Alice Nevone, Luca Arcaini, Francesca Gay, Francesco Di Raimondo, Pellegrino Musto, Eloisa Riva, Mohammed Aljama, Krzysztof Jamroziak, Roberta Shcolnik Szor, Mathias Brehon, Giampaolo Merlini, Stefan Schonland, Giovanni O. Palladini
Journal: Blood
Blood (2024) 144 (Supplement 1): 1927.1.
https://doi.org/10.1182/blood-2024-200529
Published: 2024
Journal Articles

Development of a Risk Prediction Model for 6-Month Early Mortality in Patients with Systemic Light Chain Amyloidosis Treated with Daratumumab-Based Frontline Therapy

George Mellgard, Abdul-hamid Bazarbachi, Saurabh Zanwar, Ute Hegenbart, Geethika Bodanapu, Divaya Bhutani, Guizhen Chen, Anita D'Souza, Angela Dispenzieri, Morie A. Gertz, Shaji Kumar, Suzanne Lentzsch, Paolo Milani, Eli Muchtar, Giovanni O. Palladini, Anannya Patwari, Vaishali Sanchorawala, Shikun Wang, Stefan O. Schönland, Rajshekhar Chakraborty, Andrew J. Cowan
Journal: Blood
Blood (2024) 144 (Supplement 1): 287.
https://doi.org/10.1182/blood-2024-202589
Published: 2024
Journal Articles

Model for Predicting Day-100 Stem Cell Transplant-Related Mortality in AL Amyloidosis

Eli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, Hamza Hassan, Raphael Mwangi, Matthew J. Maurer, Francis Buadi, Hans C. Lee, Muzaffar H. Qazilbash, Andrew Kin, Jeffrey A. Zonder, Sally Arai, Michelle M Chin, Rajshekhar Chakraborty, Suzanne Lentzsch, Hila Magen, Eden Shkury, Caitlin Sarubbi, Heather J. Landau, Stefan Schonland, Ute Hegenbart, Morie A. Gertz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4681.
https://doi.org/10.1182/blood-2024-206496
Published: 2024
Journal Articles

Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series

Nathalie Forgeard, Dikélélé Elessa, Alexander Carpinteiro, Karim Belhadj, Monique Minnema, Murielle Roussel, Antoine Huart, Vincent Javaugue, Laurent Pascal, Bruno Royer, Alexis Talbot, Romain Gounot, Ute Hegenbart, Stefan Schonland, Lionel Karlin, Stéphanie Harel, Efstathios Kastritis, Frank Bridoux, Arnaud Jaccard, Bertrand Arnulf
Journal: Blood
Blood (2024) 143 (8): 734–737.
https://doi.org/10.1182/blood.2023022937
Published: 2024
Journal Articles

Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study

Eli Muchtar, Giovanni Palladini, Stefan Schonland, Angela Dispenzieri, Brendan Wisniowski, Giampaolo Merlini, Paolo Milani, Ute Hegenbart, Tobias Dittrich, Efstathios Kastritis, Meletios Athanasios Dimopoulos, Vaishali Sanchorawala, Raphael E Szalat, Michaela Liedtke, Mani Gupta, Heather Landau, Suzanne Lentzsch, Michael Sang Hughes, Maria Teresa Cibeira López, Joan Bladé, Shaji Kunnathu Kumar, Ashutosh D. Wechalekar, Morie A Gertz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3411.
https://doi.org/10.1182/blood-2023-190226
Published: 2023
Journal Articles

The Impact of Melphalan Conditioning Schedule on Post-Transplant Outcomes in AL Amyloidosis: A Multicenter Study with 1718 Patients

Eli Muchtar, Vaishali Sanchorawala, Hamza Hassan, Ute Hegenbart, Stefan Schonland, Hans C. Lee, Muzaffar H. Qazilbash, Andrew Kin, Christiane A. Houde, Francis Buadi, Angela Dispenzieri, Eapen K. Jacob, Sally Arai, Michelle Chin MD, Rajshekhar Chakraborty, Suzanne Lentzsch, Hila Magen, Eden Shkury, Caitlin Sarubbi, Heather Landau, Morie A Gertz
Journal: Blood
Blood (2023) 142 (Supplement 1): 4784.
https://doi.org/10.1182/blood-2023-188115
Published: 2023
Journal Articles

Graded Renal Response Criteria for Light Chain (AL) Amyloidosis

Eli Muchtar, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan Schönland, Kaya Veelken, Ute Hegenbart, Angela Dispenzieri, Shaji Kumar, Nelson Leung, Efstathios Kastritis, Meletios A. Dimopoulos, Michaela Liedtke, Ronald Witteles, Vaishali Sanchorawala, Raphael Szalat, Heather J Landau, Erica Petrlik, Suzanne Lentzsch, Alexander Coltoff, Joan Bladé, M. Teresa Cibeira, Oliver C Cohen, Darren Foard, Julian D Gillmore, Helen J Lachmann, Ashutosh D. Wechalekar, Morie A. Gertz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2721.
https://doi.org/10.1182/blood-2021-149594
Published: 2021
Journal Articles

Graded Cardiac Response Criteria for AL Amyloidosis: The Impact of Depth of Cardiac Response on Survival

Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan Schönland, Kaya Veelken, Ute Hegenbart, Shaji Kumar, Efstathios Kastritis, Meletios A. Dimopoulos, Michaela Liedtke, Ronald Witteles, Vaishali Sanchorawala, Raphael Szalat, Heather J Landau, Erica Petrlik, Suzanne Lentzsch, Alexander Coltoff, Joan Bladé, M. Teresa Cibeira, Oliver Cohen, Darren Foard, Ashutosh D. Wechalekar, Morie A. Gertz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2720.
https://doi.org/10.1182/blood-2021-149222
Published: 2021
Journal Articles

Easix before Conditioning Therapy Predicts Sepsis after Allogeneic Stem Cell Transplantation

Felix Korell, Nicholas Schreck, Axel Benner, Tobias Liebregts, Stefan Schönland, Ute Hegenbart, Aleksandar Radujkovic, Michael Schmitt, Peter Dreger, Thomas Luft
Journal: Blood
Blood (2021) 138 (Supplement 1): 1774.
https://doi.org/10.1182/blood-2021-153104
Published: 2021
Journal Articles

Th22 and Tfh Cell Elevation Is Associated with Clinical Response of Photopheresis Therapy in Patients with Steroid-Refractory/ Resistant Graft-Versus-Host Disease (GvHD)

Yuntian Ding, Lei Wang, Ming Ni, Wenjie Gong, Sanmei Wang, Brigitte Neuber, Maria-Luisa Schubert, Tim Sauer, Angela Hückelhoven-Krauss, Thomas Luft, Ute Hegenbart, Stefan Schönland, Volker Eckstein, Jishi Wang, William Hermann Krüger, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Anita Schmitt
Journal: Blood
Blood (2021) 138 (Supplement 1): 1810.
https://doi.org/10.1182/blood-2021-150106
Published: 2021
Journal Articles

Two-Year Evaluation of the German Clinical Amyloidosis Registry

Ute Hegenbart, Niklas Fuhr, Laura Huber, Christoph Kimmich, Kaya Veelken, Tobias Dittrich, Rita Ziehl, Fabian aus dem Siepen, Alexander Carpinteiro, Timon Hansen, Carsten Müller-Tidow, Axel Benner, Stefan Schönland
Journal: Blood
Blood (2021) 138 (Supplement 1): 3780.
https://doi.org/10.1182/blood-2021-152713
Published: 2021
Journal Articles

Multi-Modality Imaging Reveals Structural Centrosome Aberrations As a Potential Driver of Chromosomal Instability in Early-Stage Plasma Cell Disorders

Sebastian Köhrer, Tobias Dittrich, Martin Schorb, Niels Weinhold, Isabella Haberbosch, Mandy Börmel, Gabor Pajor, Hartmut Goldschmidt, Carsten Müller-Tidow, Marc-Steffen Raab, Alexander Brobeil, Peter Dreger, Ute Hegenbart, Stefan Schönland, Yannick Schwab, Alwin Krämer
Journal: Blood
Blood (2021) 138 (Supplement 1): 1579.
https://doi.org/10.1182/blood-2021-150747
Published: 2021
Journal Articles

Systemic Light Chain Amyloidosis across Europe: Key Outcomes from a Retrospective Study of 4500 Patients

Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios A. Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M. Teresa Cibeira, Hermine Agis, Monique C. Minnema, Rui Bergantim, Roman Hajek, Cristina João, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D. Wechalekar
Journal: Blood
Blood (2021) 138 (Supplement 1): 153.
https://doi.org/10.1182/blood-2021-152675
Published: 2021
Journal Articles

Light Chain Deposition Disease: First Analysis of an International Study in 359 Patients

Paolo Milani, MDPhD, Nelson Leung, MD, Efstathios Kastritis, MD, Stefan Schönland, MD, Ute Hegenbart, MD, Frank Bridoux, MD, Florent Joly, MD, Sascha A Tuchman, MD, Victor Jimenez-Zepeda, MD, Sriram Ravichandran, MBBS, MRCP, FRCPath, Holly Lee, MD, Tamara Berno, MD, Giampaolo Merlini, MD, Giovanni Palladini, MD PhD, Ashutosh D. Wechalekar, MBBS,FRCP,FRCPath,DM
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-141662
Published: 2020
Journal Articles

Gain 1q21 Is an Adverse Prognostic Factor in Patients with Relapsed/Refractory AL Amyloidosis Treated with Lenalidomide and Dexamethasone

Marco Basset, MD, Christoph Kimmich, Tobias Dittrich, MD, Kaya Veelken, MD, Hartmut Goldschmidt, MD, Dirk Hose, MD, Anja Seckinger, MD, Anna Jauch, Carsten Mueller-Tidow, MD, Ute Hegenbart, MD, Stefan Schönland, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-142701
Published: 2020
Journal Articles

Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria

Clinical Trials & Observations
Christoph R. Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinteiro, Timon Hansen, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Anna Jauch, Stefan Wörner, Jörg Beimler, Carsten Müller-Tidow, Ute Hegenbart, Stefan O. Schönland
Journal: Blood
Blood (2020) 135 (18): 1517–1530.
https://doi.org/10.1182/blood.2019003633
Published: 2020
Includes: Supplemental data
Journal Articles

Incidence, Risk Factors, Treatment and Long Term Outcome of Refractory and First Relapse AML Patients in the OSHO Studies

Dietger Niederwieser, MD, Rainer Krahl, PhD, Christoph Kahl, MD, Hans-Heinrich Wolf, MD, Sebastian Scholl, Michael Cross, PhD, Ute Hegenbart, MD, Norma Peter, MD, Christian Niederwieser, MD, Axel Florschütz, Kolija Reifenrath, Niklas Zojer, Christian Jakob, MD, Christian Junghanss, MD, Herbert G. Sayer, MD PhD, Volker Schmidt, Sebastian Schwind, MD, Georg Maschmeyer, MD, Thomas Fischer, MD, Andreas Hochhaus, MD, Haifa Kathrin Al-Ali, MD, Thomas Heinicke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1358.
https://doi.org/10.1182/blood-2019-125262
Published: 2019
Journal Articles

High-Throughput Immunofluorescence and Electron Tomography to Characterize Centrosomal Aberrations in Plasma Cell Neoplasia

Tobias Dittrich, MD, Martin Schorb, Isabella Haberbosch, MD, Elena Bausch, PhD, Mandy Börmel, Marco Cosenza, PhD, Hartmut Goldschmidt, MD, Carsten Müller-Tidow, MD, Marc S Raab, MD PhD, Ute Hegenbart, MD, Stefan O. Schönland, MD, Yannick Schwab, PhD, Alwin Krämer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3077.
https://doi.org/10.1182/blood-2019-130713
Published: 2019
Journal Articles

The Impact of Allogeneic Hematopoietic Cell Transplantation (alloHCT) on the Outcome of Poor-Risk Non-Hodgkin Lymphoma (NHL): A Retrospective Intent-to-Transplant (ITT) Analysis

Lorenz Selberg, Peter Stadtherr, Sascha Dietrich, MD, Thomas Luft, MD PhD, Andrea Bondong, Ute Hegenbart, MD, Julia Meissner, MD, Nora Liebers, Michael Schmitt, MD, Carsten Mueller-Tidow, MD, Peter Dreger
Journal: Blood
Blood (2019) 134 (Supplement_1): 3328.
https://doi.org/10.1182/blood-2019-128352
Published: 2019